U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
For the Period Ended September 30, 1999
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
Part I--Registrant Information
U.S. Microbics, Inc.
-----------------------
(Full Name of Registrant)
5922-B Farnsworth Court
Carlsbad, California 92008
- --------------------------------------------------------------------------------
(Address, including city, state and zip code, of Principal Executive Office)
Part II--Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[X] The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and
[X] The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
Part III--Narrative
The filing of the subject Form 10-KSB could not be accomplished by the
filing date without unreasonable effort or expense due to delays in the
completion of the Company's audit for the fiscal year ended September 30, 1999.
<PAGE>
Part IV--Other Information
Mr. Conrad Nagel - Chief Financial Officer
U.S. Microbics, Inc.
5922-B Farnsworth Court
Carlsbad, California 92008
(760) 918-1860
- --------------------------------------------------------------------------------
(Name and telephone number of person to contact in regard to this notification)
Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s). [X] Yes [ ] No
Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
U.S. Microbics, Inc. has caused this notification to be signed on its
behalf by the undersigned thereunto duly authorized on December 29, 1999.
U.S. MICROBICS, INC.
By: /s/ Conrad Nagel
----------------------------------
Conrad Nagel
Chief Financial Officer
<PAGE>
United States Securities and Exchange Commission
Washington, D.C. 20549
Gentlemen:
We were retained by U.S. Microbics, Inc. and Subsidiaries on November 22, 1999
as independent auditors to report on the consolidated financial statements at
September 30, 1999 and for the fiscal year then ended. We have endeavored, with
the cooperation of the Company, to obtain the necessary information to meet the
filing requirements for Form 10-KSB, both as to form and timeliness. Due to the
amount of time necessary to plan and perform our auditing procedures and the
extensive amount of information requested by us from the Company and third
parties, we do not have all of the necessary information to complete the audit
and, as such, we will be unable to complete our audit by December 29, 1999,
which is the required filing date for the Company's annual report.
/s/ Bradshaw, Smith & Co. LLP
- -----------------------------
Bradshaw, Smith & Co. LLP
Las Vegas, Nevada
December 29, 1999
